Rare Connection

EveryCat Health Foundation: The Cat Connection to Long Covid Part 2 With Dr Maggie Placer

Joanna Season 7 Episode 2

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 33:17

Send us Fan Mail

n Part 2 of my conversation with Dr. Maggie Placer from EveryCat Health Foundation, we continue our discussion of the One Health approach and the surprising connections between veterinary and human medicine.

This episode explores how research that began with treating cats has contributed to a broader understanding of antiviral therapies and why researchers are now studying Remdesivir as a potential treatment for Long COVID in humans. While the research is ongoing, it highlights how collaboration across medical and veterinary fields can accelerate scientific discovery.

Whether you're interested in rare diseases, infectious diseases, veterinary medicine, or emerging medical research, this conversation offers a fascinating look at how breakthroughs can cross the boundaries between species.

If you missed Part 1, be sure to listen to the previous episode for the beginning of this conversation.

Guest: Dr. Maggie Placer, EveryCat Health Foundation

In this episode:

  • What One Health means in practice
  • How feline antiviral research has informed human medicine
  • Why researchers are investigating antivirals for Long COVID
  • The value of collaboration between veterinary and human healthcare

Thank you for listening to Rare Connection, where we connect patients, caregivers, clinicians, researchers, and advocates to educate, inspire, and advance awareness of rare diseases and emerging medical discove

Support the show